Suppr超能文献

相似文献

1
Podocyte-specific expression of organic cation transporter PMAT: implication in puromycin aminonucleoside nephrotoxicity.
Am J Physiol Renal Physiol. 2009 Jun;296(6):F1307-13. doi: 10.1152/ajprenal.00046.2009. Epub 2009 Apr 8.
3
Adenosine transport by plasma membrane monoamine transporter: reinvestigation and comparison with organic cations.
Drug Metab Dispos. 2010 Oct;38(10):1798-805. doi: 10.1124/dmd.110.032987. Epub 2010 Jun 30.
4
Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells.
Am J Physiol Renal Physiol. 2007 Feb;292(2):F682-90. doi: 10.1152/ajprenal.00302.2006. Epub 2006 Oct 3.
8
Podocyte expression of membrane transporters involved in puromycin aminonucleoside-mediated injury.
PLoS One. 2013 Jun 20;8(6):e66159. doi: 10.1371/journal.pone.0066159. Print 2013.
9
Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
Clin Exp Nephrol. 2009 Oct;13(5):438-446. doi: 10.1007/s10157-009-0196-0. Epub 2009 May 19.
10
Interaction of organic cations with a newly identified plasma membrane monoamine transporter.
Mol Pharmacol. 2005 Nov;68(5):1397-407. doi: 10.1124/mol.105.016832. Epub 2005 Aug 11.

引用本文的文献

1
ATP/ADP biosensor organoids for drug nephrotoxicity assessment.
Front Cell Dev Biol. 2023 Mar 2;11:1138504. doi: 10.3389/fcell.2023.1138504. eCollection 2023.
2
The Role of in the Puromycin Aminonucleoside-Induced Morphological Change of Podocytes.
Noncoding RNA. 2022 Jun 8;8(3):43. doi: 10.3390/ncrna8030043.
4
Membrane Carriers and Transporters in Kidney Physiology and Disease.
Biomedicines. 2021 Apr 14;9(4):426. doi: 10.3390/biomedicines9040426.
5
6
mRNAs in urinary nano-extracellular vesicles as potential biomarkers for non-invasive kidney biopsy.
Biomed Rep. 2021 Jan;14(1):11. doi: 10.3892/br.2020.1387. Epub 2020 Nov 12.
7
Advances in predictive in vitro models of drug-induced nephrotoxicity.
Nat Rev Nephrol. 2018 Jun;14(6):378-393. doi: 10.1038/s41581-018-0003-9.
8
The plasma membrane monoamine transporter (PMAT): Structure, function, and role in organic cation disposition.
Clin Pharmacol Ther. 2016 Nov;100(5):489-499. doi: 10.1002/cpt.442. Epub 2016 Sep 19.
9
Small molecule membrane transporters in the mammalian podocyte: a pathogenic and therapeutic target.
Int J Mol Sci. 2014 Nov 18;15(11):21366-80. doi: 10.3390/ijms151121366.
10
Podocyte expression of membrane transporters involved in puromycin aminonucleoside-mediated injury.
PLoS One. 2013 Jun 20;8(6):e66159. doi: 10.1371/journal.pone.0066159. Print 2013.

本文引用的文献

1
Inducible rodent models of acquired podocyte diseases.
Am J Physiol Renal Physiol. 2009 Feb;296(2):F213-29. doi: 10.1152/ajprenal.90421.2008. Epub 2008 Sep 10.
4
Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity.
Biochem Pharmacol. 2007 Aug 1;74(3):477-87. doi: 10.1016/j.bcp.2007.03.004. Epub 2007 Mar 12.
5
Transport of paraquat by human organic cation transporters and multidrug and toxic compound extrusion family.
J Pharmacol Exp Ther. 2007 Aug;322(2):695-700. doi: 10.1124/jpet.107.123554. Epub 2007 May 10.
6
The dopaminergic system in hypertension.
Clin Sci (Lond). 2007 Jun;112(12):583-97. doi: 10.1042/CS20070018.
8
Molecular determinants of substrate selectivity of a novel organic cation transporter (PMAT) in the SLC29 family.
J Biol Chem. 2007 Feb 2;282(5):3188-95. doi: 10.1074/jbc.M609421200. Epub 2006 Nov 22.
9
Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells.
Am J Physiol Renal Physiol. 2007 Feb;292(2):F682-90. doi: 10.1152/ajprenal.00302.2006. Epub 2006 Oct 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验